SFCM
AGIO icon

Seven Fleet Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Seven Fleet Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.09M Buy
209,547
+177,809
+560% +$5.04M 2.23% 6
2025
Q4 		$864K Buy
+31,738
New +$1.11M 0.58% 33

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $508M AUM 163.77% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Seven Fleet Capital Management's AGIO Position: Q1 2026 in Review

Seven Fleet Capital Management increased its Agios Pharmaceuticals (AGIO) stake by 560% in Q1 2026, buying an estimated $5.04M and bringing the position to 209,547 shares worth $7.09M. The position accounts for 2.23% of the portfolio, ranked #6.

Seven Fleet Capital Management first reported a position in AGIO in Q4 2025 and has held it in 2 quarters since. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Seven Fleet Capital Management held 209,547 shares of Agios Pharmaceuticals worth $7.09M as of Q1 2026.
  • Seven Fleet Capital Management bought 177,809 Agios Pharmaceuticals shares in Q1 2026, an estimated $5.04M.
  • Agios Pharmaceuticals made up 2.23% of Seven Fleet Capital Management's portfolio in Q1 2026, its #6 holding.
  • Seven Fleet Capital Management first reported a position in Agios Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.